FI945900A0 - Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksi - Google Patents
Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksiInfo
- Publication number
- FI945900A0 FI945900A0 FI945900A FI945900A FI945900A0 FI 945900 A0 FI945900 A0 FI 945900A0 FI 945900 A FI945900 A FI 945900A FI 945900 A FI945900 A FI 945900A FI 945900 A0 FI945900 A0 FI 945900A0
- Authority
- FI
- Finland
- Prior art keywords
- group
- substituted
- unsubstituted
- formula
- single bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31877993 | 1993-12-17 | ||
| JP31877993 | 1993-12-17 | ||
| JP14062894 | 1994-06-23 | ||
| JP14062894 | 1994-06-23 | ||
| JP18355394 | 1994-08-04 | ||
| JP18355394 | 1994-08-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI945900A0 true FI945900A0 (fi) | 1994-12-15 |
| FI945900A FI945900A (fi) | 1995-06-18 |
| FI115137B FI115137B (fi) | 2005-03-15 |
Family
ID=27318092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI945900A FI115137B (fi) | 1993-12-17 | 1994-12-15 | Menetelmä terapeuttisesti käyttökelpoisen bentseenisulfon-amidijohdannaisen valmistamiseksi |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5589478A (fi) |
| EP (1) | EP0658548B1 (fi) |
| KR (1) | KR100250176B1 (fi) |
| CN (1) | CN1051544C (fi) |
| AT (1) | ATE160341T1 (fi) |
| AU (1) | AU676620B2 (fi) |
| CA (1) | CA2137953C (fi) |
| DE (1) | DE69406900T2 (fi) |
| DK (1) | DK0658548T3 (fi) |
| ES (1) | ES2111237T3 (fi) |
| FI (1) | FI115137B (fi) |
| GR (1) | GR3025855T3 (fi) |
| HK (1) | HK1004333A1 (fi) |
| IL (1) | IL111959A (fi) |
| MY (1) | MY130908A (fi) |
| SG (1) | SG52234A1 (fi) |
| TW (1) | TW430661B (fi) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5736509A (en) * | 1990-12-14 | 1998-04-07 | Texas Biotechnology Corporation | Cyclic peptide surface feature mimics of endothelin |
| US6030991A (en) * | 1993-05-20 | 2000-02-29 | Texas Biotechnology Corp. | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6541498B2 (en) | 1993-05-20 | 2003-04-01 | Texas Biotechnology | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| US6376523B1 (en) | 1994-05-20 | 2002-04-23 | Texas Biotechnology Corporation | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| TW313568B (fi) * | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
| DK0799206T3 (da) * | 1994-12-20 | 2003-01-27 | Hoffmann La Roche | Aryl- og heteroaryl-sulfonamidderivater, fremstillingen deraf og anvendelsen deraf som endothelinantagonister |
| CN1171785A (zh) * | 1994-12-28 | 1998-01-28 | 兴和株式会社 | 嘧啶衍生物 |
| US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| AU703892B2 (en) * | 1995-09-06 | 1999-04-01 | Kowa Co., Ltd. | Pyrimidine derivatives |
| CZ260596A3 (en) * | 1995-10-12 | 1997-12-17 | Hoffmann La Roche | Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof |
| EP0882719B1 (en) * | 1995-12-20 | 2001-05-16 | Yamanouchi Pharmaceutical Co. Ltd. | Arylethenesulfonamide derivatives and drug composition containing the same |
| US5977117A (en) | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
| US5958905A (en) | 1996-03-26 | 1999-09-28 | Texas Biotechnology Corporation | Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| US5804585A (en) * | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| CN1067821C (zh) * | 1997-03-13 | 2001-06-27 | 倚天资讯股份有限公司 | 一种互联网实时广播装置及其方法 |
| US6432994B1 (en) | 1997-04-28 | 2002-08-13 | Texas Biotechnology Corporation | Sulfonamides for treatment of endothelin-mediated disorders |
| US5783705A (en) * | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| CA2326427A1 (en) | 1998-03-31 | 1999-10-07 | Koichiro Yamada | Preventives/remedies for urinary disorder |
| DE69919707T2 (de) | 1998-06-19 | 2005-09-01 | Chiron Corp., Emeryville | Glycogen synthase kinase 3 inhibitoren |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6136971A (en) * | 1998-07-17 | 2000-10-24 | Roche Colorado Corporation | Preparation of sulfonamides |
| CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
| GB0013368D0 (en) * | 2000-05-31 | 2000-07-26 | Pfizer Ltd | Enzymatic oxidations |
| AU2001263850A1 (en) * | 2000-04-20 | 2001-11-07 | Actelion Pharmaceuticals Ltd | Pyrimidine-sulfonamides having endothelin-antagonist activity |
| WO2001081338A1 (en) * | 2000-04-25 | 2001-11-01 | Actelion Pharmaceuticals Ltd | Substituted sulfonylaminopyrimidines |
| US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
| US6610518B2 (en) | 2000-05-31 | 2003-08-26 | Pfizer Inc. | Enzymatic oxidations |
| CA2348847A1 (en) * | 2000-05-31 | 2001-11-30 | Pfizer Inc. | New isoxazole-sulfonamide endothelin antagonists |
| MY140724A (en) | 2000-07-21 | 2010-01-15 | Actelion Pharmaceuticals Ltd | Novel arylethene-sulfonamides |
| US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| US20020091114A1 (en) | 2000-10-04 | 2002-07-11 | Odile Piot-Grosjean | Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity |
| AU2011218661B2 (en) * | 2002-05-24 | 2012-07-05 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
| NZ536504A (en) * | 2002-05-24 | 2008-04-30 | Millennium Pharm Inc | CCR9 inhibitors and methods of use thereof |
| PT1562940E (pt) * | 2002-11-18 | 2007-07-23 | Chemocentryx Inc | Sulfonamidas de arilo. |
| US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
| US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
| US7741519B2 (en) * | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
| CN100379730C (zh) | 2002-12-02 | 2008-04-09 | 埃科特莱茵药品有限公司 | 嘧啶-磺酰胺及其作为内皮素受体拮抗剂的应用 |
| US20050131028A1 (en) * | 2003-09-11 | 2005-06-16 | Pharmacia Corporation | Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders |
| EP1725540B1 (en) | 2004-03-05 | 2012-09-12 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| TW200628467A (en) | 2004-11-11 | 2006-08-16 | Actelion Pharmaceuticals Ltd | Novel sulfamides |
| CN101296907B (zh) | 2005-09-01 | 2013-03-27 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3和p2x2/3调节剂的二氨基嘧啶类 |
| CA2620129C (en) | 2005-09-01 | 2014-12-23 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| ES2601178T3 (es) | 2005-09-01 | 2017-02-14 | F. Hoffmann-La Roche Ag | Diaminopirimidinas como moduladores de P2X3 y P3X2/3 |
| BRPI0709950A2 (pt) * | 2006-04-13 | 2011-08-02 | Actelion Pharmaceuticals Ltd | uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin |
| AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
| ES2376375T3 (es) * | 2007-12-18 | 2012-03-13 | Dipharma Francis S.R.L. | Procedimiento para la preparación de bosent�?n. |
| WO2009143183A1 (en) * | 2008-05-19 | 2009-11-26 | University Of Tennessee Research Foundation, The | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| WO2010032261A1 (en) * | 2008-08-12 | 2010-03-25 | Cadila Healthcare Limited | Process for preparation of bosentan |
| WO2011078143A1 (ja) * | 2009-12-22 | 2011-06-30 | 塩野義製薬株式会社 | ピリミジン誘導体およびそれらを含有する医薬組成物 |
| WO2014093230A2 (en) * | 2012-12-10 | 2014-06-19 | Merck Patent Gmbh | Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
| KR20200090747A (ko) | 2017-09-12 | 2020-07-29 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 이소프레닐시스테인 카복실 메틸트랜스퍼라제의 억제제로 유용한 화합물 |
| CN107778254A (zh) * | 2017-12-07 | 2018-03-09 | 陈国妃 | 抗病毒药物中间体氧代二嘧啶衍生物的合成方法 |
| WO2023078463A1 (zh) * | 2021-11-08 | 2023-05-11 | 正大天晴药业集团股份有限公司 | 氮杂联苯类化合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545944A1 (de) * | 1964-06-19 | 1969-12-11 | Hoffmann La Roche | Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe |
| TW270116B (fi) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| TW287160B (fi) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche |
-
1994
- 1994-12-12 IL IL11195994A patent/IL111959A/xx not_active IP Right Cessation
- 1994-12-13 CA CA002137953A patent/CA2137953C/en not_active Expired - Fee Related
- 1994-12-14 AU AU80461/94A patent/AU676620B2/en not_active Ceased
- 1994-12-15 TW TW083111723A patent/TW430661B/zh not_active IP Right Cessation
- 1994-12-15 AT AT94119833T patent/ATE160341T1/de not_active IP Right Cessation
- 1994-12-15 ES ES94119833T patent/ES2111237T3/es not_active Expired - Lifetime
- 1994-12-15 FI FI945900A patent/FI115137B/fi not_active IP Right Cessation
- 1994-12-15 EP EP94119833A patent/EP0658548B1/en not_active Expired - Lifetime
- 1994-12-15 DK DK94119833.5T patent/DK0658548T3/da active
- 1994-12-15 SG SG1996000959A patent/SG52234A1/en unknown
- 1994-12-15 DE DE69406900T patent/DE69406900T2/de not_active Expired - Lifetime
- 1994-12-16 MY MYPI94003378A patent/MY130908A/en unknown
- 1994-12-16 US US08/356,958 patent/US5589478A/en not_active Expired - Lifetime
- 1994-12-17 CN CN94119413A patent/CN1051544C/zh not_active Expired - Fee Related
- 1994-12-17 KR KR1019940034840A patent/KR100250176B1/ko not_active IP Right Cessation
-
1996
- 1996-04-24 US US08/636,981 patent/US5728706A/en not_active Expired - Lifetime
-
1998
- 1998-01-08 GR GR980400025T patent/GR3025855T3/el unknown
- 1998-04-27 HK HK98103547A patent/HK1004333A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR950017972A (ko) | 1995-07-22 |
| AU8046194A (en) | 1995-06-22 |
| EP0658548A1 (en) | 1995-06-21 |
| CA2137953A1 (en) | 1995-06-18 |
| EP0658548B1 (en) | 1997-11-19 |
| DE69406900D1 (de) | 1998-01-02 |
| IL111959A0 (en) | 1995-06-29 |
| US5589478A (en) | 1996-12-31 |
| DE69406900T2 (de) | 1998-04-09 |
| AU676620B2 (en) | 1997-03-13 |
| SG52234A1 (en) | 1998-09-28 |
| GR3025855T3 (en) | 1998-04-30 |
| MY130908A (en) | 2007-07-31 |
| CA2137953C (en) | 2002-03-26 |
| US5728706A (en) | 1998-03-17 |
| HK1004333A1 (en) | 1998-11-20 |
| ATE160341T1 (de) | 1997-12-15 |
| FI945900A (fi) | 1995-06-18 |
| IL111959A (en) | 2000-07-16 |
| KR100250176B1 (ko) | 2000-09-01 |
| CN1051544C (zh) | 2000-04-19 |
| TW430661B (en) | 2001-04-21 |
| ES2111237T3 (es) | 1998-03-01 |
| CN1111242A (zh) | 1995-11-08 |
| FI115137B (fi) | 2005-03-15 |
| DK0658548T3 (da) | 1998-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI945900A0 (fi) | Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksi | |
| KR0138695B1 (en) | Nitrogenous heterocyclic compound c 07 d 235/00 | |
| MX9306831A (es) | Nuevos compuestos heterociclicos. | |
| DE69321525D1 (de) | Morphinan-derivate und medizinische verwendung | |
| DK0622361T3 (da) | Heterocykliske forbindelser som bradykininantagonister | |
| ES2082780T3 (es) | Derivados de acido bisfosfonico heterociclicos. | |
| IL97161A0 (en) | Thiazine and oxazine derivatives,their preparation and pharmaceutical compositions containing them | |
| ATE81655T1 (de) | Cephemverbindungen und verfahren zu ihrer herstellung. | |
| DK148288D0 (da) | N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne | |
| EP0801062A4 (en) | PYRIMIDINIC DERIVATIVES | |
| AU632877B2 (en) | Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| FR2598914B1 (fr) | Composition prophylactique et curative pour l'arteriosclerose | |
| IL110369A0 (en) | Pharmaceutical compositions for the prevention and/or treatment of gastrointestinal diseases including ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 115137 Country of ref document: FI |
|
| MA | Patent expired |